Research Paper Volume 15, Issue 18 pp 9779—9796
Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
Figure 3. (A) Correlation between NDC1 expression and immune cell infiltration (CIBERSORT) (red represents positive correlation, and blue represents negative correlation). (B) TME analysis in PAAD (red for high-expression and yellow-green for low-expression).